- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07656610
Respiratory Muscle Training and Walking Exercise in Women Recovering From COVID-19 Pneumonia (RECOVID-EX)
Investigation of the Effects of Respiratory Muscle Training and Walking Exercises on Some Blood and Respiratory Parameters in Patients Recovering From COVID-19 Lung Inflammation
This experimental study was designed to investigate the effects of respiratory muscle training and walking exercise on selected blood, respiratory, functional, dyspnea, sleep quality, and quality-of-life outcomes in women who had recovered from COVID-19-related lung inflammation/pneumonia. The study included women aged 20 to 45 years who had experienced COVID-19 with pneumonia, reported dyspnea, and had reduced quality of life.
A total of 80 female participants were divided into four groups: respiratory muscle training plus walking exercise, respiratory muscle training alone, walking exercise alone, and a control group, with 20 participants in each group. Measurements were performed before and after the intervention period. The assessments included pulmonary function testing, maximal inspiratory pressure, the 6-minute walk test, the modified Borg scale for dyspnea, the Nottingham Health Profile, the Pittsburgh Sleep Quality Index, and selected blood parameters. The study aimed to determine whether respiratory muscle training, walking exercise, or their combination could improve respiratory function, inspiratory muscle strength, functional capacity, dyspnea, sleep quality, quality of life, and blood-related parameters in this population.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
This was a single-blind, experimental, pretest-posttest intervention study conducted in adult women who had recovered from COVID-19-related pneumonia and continued to experience dyspnea during the post-discharge period. Participants were recruited from routine post-discharge follow-up settings and were informed about the study procedures before participation. Written informed consent was obtained from all participants before any study-related procedures were performed.
Before the start of the intervention period, participants completed a familiarization session and trial measurements to reduce learning-related variability during the actual assessments. Baseline measurements were then performed, and participants were allocated into four study groups according to their pretest results: respiratory muscle training, respiratory muscle training plus walking exercise, walking exercise, and control.
The respiratory muscle training intervention was performed for 8 weeks using a pressure-threshold respiratory muscle training device. The training load was set at 50% of each participant's maximal inspiratory pressure. Participants in the respiratory muscle training group performed the intervention 5 days per week, twice daily, with 30 breaths in each session. Respiratory muscle strength was reassessed weekly, and the training load was updated according to changes in maximal inspiratory pressure.
The combined intervention group completed the same respiratory muscle training protocol in addition to a structured walking exercise program. The walking exercise consisted of 40 minutes of walking, 3 days per week, either outdoors or on a treadmill, at a pace of approximately 4 to 6 km/hour. Exercise intensity was prescribed using a target heart rate approach corresponding to 40% intensity and was monitored during the sessions with an optical heart rate sensor. Before walking exercise, participants completed a 10-minute warm-up and stretching routine for the upper and lower extremities.
The walking exercise group completed only the structured walking program using the same frequency, duration, intensity, and monitoring procedures as the walking component of the combined intervention group. The control group did not receive a structured exercise intervention and continued their usual daily routine during the study period.
Study data were collected using individual participant forms. These forms included health history, medication use, smoking status, previous physical activity status, basic physical characteristics, and all pre- and post-intervention measurement values. The intervention process and exercise sessions were monitored throughout the study period. Measurements were repeated after the 8-week intervention period to evaluate changes within and between the study groups.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Çorum
-
Çorum, Çorum, Turquía (Türkiye), 19100
- Hitit University Corum Erol Olçok Training and Research Hospital
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Female participants aged 20 to 45 years
- History of COVID-19-related pneumonia
- Presence of dyspnea after COVID-19
- Modified Borg dyspnea score between 1 and 7 after the 6-minute walk test
- Resting oxygen saturation between 90% and 95%
- Incomplete resolution of COVID-19-related lesions on chest radiography
- Voluntary agreement to participate in the study
- Signed written informed consent form
Exclusion Criteria:
- Modified Borg dyspnea score between 0 and 1
- Modified Borg dyspnea score greater than 7
- History of chronic obstructive pulmonary disease, heart failure, or pulmonary fibrosis causing dyspnea before COVID-19 pneumonia
- Upper abdominal or thoracic surgery within the previous 3 months
- Cancer
- Pregnancy
- Presence of another disease contributing to dyspnea in addition to COVID-19-related dyspnea
- Cardiovascular, musculoskeletal, or nervous system involvement related to COVID-19
- Mental disorder or mental instability
- Language barrier preventing understanding of Turkish
- Refusal to participate or withdrawal from the study at any stage
- History of being a competitive athlete
- Lack of voluntary participation or refusal to sign the written informed consent form
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: No aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Respiratory Muscle Training
Participants in this arm received respiratory muscle training for 8 weeks using a pressure-threshold respiratory muscle training device.
The training intensity was set at 50% of each participant's maximal inspiratory pressure and was updated according to weekly changes in respiratory muscle strength.
|
Participants performed respiratory muscle training for 8 weeks using a pressure-threshold respiratory muscle training device.
The training load was set at 50% of each participant's maximal inspiratory pressure.
Training was performed 5 days per week, twice daily, with 30 breaths in each session.
Maximal inspiratory pressure was reassessed weekly, and the training load was adjusted according to the updated value.
|
|
Experimental: Respiratory Muscle Training Plus Walking Exercise
Participants in this arm received respiratory muscle training in addition to a structured walking exercise program for 8 weeks.
The walking exercise was performed 3 days per week for 40 minutes at 40% intensity based on the target heart rate method, either outdoors or on a treadmill.
Exercise intensity was monitored using an optical heart rate sensor.
|
Participants performed respiratory muscle training for 8 weeks using a pressure-threshold respiratory muscle training device.
The training load was set at 50% of each participant's maximal inspiratory pressure.
Training was performed 5 days per week, twice daily, with 30 breaths in each session.
Maximal inspiratory pressure was reassessed weekly, and the training load was adjusted according to the updated value.
Participants performed a structured walking exercise program for 8 weeks.
Walking exercise was performed 3 days per week for 40 minutes at an intensity corresponding to 40% based on the target heart rate method.
Walking was performed either outdoors or on a treadmill at an approximate pace of 4 to 6 km/hour.
Exercise intensity was monitored using a Polar Verity Sense optical heart rate sensor.
Before walking, participants completed a 10-minute warm-up and stretching protocol for the upper and lower extremities.
|
|
Experimental: Walking Exercise
Participants in this arm performed structured walking exercise for 8 weeks.
Walking was performed 3 days per week for 40 minutes at a pace of approximately 4-6 km/hour and at 40% intensity based on the target heart rate method.
Exercise intensity was monitored during the sessions using an optical heart rate sensor.
|
Participants performed a structured walking exercise program for 8 weeks.
Walking exercise was performed 3 days per week for 40 minutes at an intensity corresponding to 40% based on the target heart rate method.
Walking was performed either outdoors or on a treadmill at an approximate pace of 4 to 6 km/hour.
Exercise intensity was monitored using a Polar Verity Sense optical heart rate sensor.
Before walking, participants completed a 10-minute warm-up and stretching protocol for the upper and lower extremities.
|
|
Sin intervención: Control
Participants in this arm did not receive any structured exercise intervention and continued their usual daily routine during the study period.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Maximal Inspiratory Pressure
Periodo de tiempo: Baseline and Week 8
|
Change in maximal inspiratory pressure from baseline to post-intervention.
Maximal inspiratory pressure was used to assess inspiratory respiratory muscle strength.
|
Baseline and Week 8
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in Forced Vital Capacity
Periodo de tiempo: Baseline and Week 8
|
Change in forced vital capacity from baseline to Week 8. Forced vital capacity was assessed using pulmonary function testing and reported in liters.
|
Baseline and Week 8
|
|
Change in Forced Expiratory Volume in 1 Second
Periodo de tiempo: Baseline and Week 8
|
Change in forced expiratory volume in 1 second from baseline to Week 8. Forced expiratory volume in 1 second was assessed using pulmonary function testing and reported in liters.
|
Baseline and Week 8
|
|
Change in Peak Inspiratory Flow
Periodo de tiempo: Baseline and Week 8
|
Change in peak inspiratory flow from baseline to Week 8. Peak inspiratory flow was assessed as a respiratory function parameter and reported in liters per second.
|
Baseline and Week 8
|
|
Change in Inspiratory Volume
Periodo de tiempo: Baseline and Week 8
|
Change in inspiratory volume from baseline to Week 8. Inspiratory volume was assessed as a respiratory function parameter and reported in liters.
|
Baseline and Week 8
|
|
Change in 6-Minute Walk Test Distance
Periodo de tiempo: Baseline and Week 8
|
Change in functional exercise capacity from baseline to post-intervention, assessed by the 6-minute walk test.
|
Baseline and Week 8
|
|
Change in Modified Borg Dyspnea Score
Periodo de tiempo: Baseline and Week 8
|
Change in perceived dyspnea from baseline to post-intervention, assessed using the modified Borg scale.
|
Baseline and Week 8
|
|
Change in Nottingham Health Profile Score
Periodo de tiempo: Baseline and Week 8
|
Change in health-related quality of life from baseline to post-intervention, assessed using the Nottingham Health Profile.
|
Baseline and Week 8
|
|
Change in Pittsburgh Sleep Quality Index Score
Periodo de tiempo: Baseline and Week 8
|
Change in sleep quality from baseline to post-intervention, assessed using the Pittsburgh Sleep Quality Index.
|
Baseline and Week 8
|
|
Change in Blood Parameters
Periodo de tiempo: Baseline and Week 8
|
Change in selected blood parameters from baseline to post-intervention, including leukocyte count, erythrocyte count, and hemoglobin.
|
Baseline and Week 8
|
Colaboradores e Investigadores
Patrocinador
Publicaciones y enlaces útiles
Publicaciones Generales
- Tosun MI. Investigation of the Effects of Respiratory Muscle Training and Walking Exercises on Some Blood and Respiratory Parameters in Patients Recovered From COVID-19 Lung Inflammation. Doctoral dissertation. Hitit University, Graduate School, Department of Physical Education and Sports; 2023.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Infecciones del Tracto Respiratorio
- Infecciones
- Infecciones por virus de ARN
- Enfermedades virales
- Enfermedades de las vías respiratorias
- Enfermedades pulmonares
- Trastornos de la respiración
- Neumonía Viral
- Neumonía
- Infecciones por coronavirus
- Infecciones por coronaviridae
- Infecciones por Nidovirales
- Condiciones Patológicas, Signos y Síntomas
- Signos y síntomas
- COVID-19
- Disnea
- Signos y Síntomas Respiratorios
- Terapéutica
- Terapias de la mente-cuerpo
- Terapias complementarias
- Técnicas de movimiento del ejercicio
- Modalidades de fisioterapia
- Ejercicios de respiración
Otros números de identificación del estudio
- 2022-98
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .